Top 10 most significant diagnoses. by Lucas Vega (19500790)

Table_1_The Significance of EEG Alpha Oscillation Spectral Power and Beta Oscillation Phase Synchronization for Diagnosing Probable Alzheimer Disease.docx by Haifeng Zhang (137541)

“…In most brain areas, we found that the AD group had significant differences compared to NC group: (1) decreased α oscillation power and increased θ oscillation power; (2) decreased spectral entropy in α oscillation and elevated spectral entropy in β oscillation; and (3) decrease phase synchronization index in δ, θ, and β oscillation. …”

Demographic and clinical characteristics of patients with newly diagnosed multiple myeloma and monoclonal gammopathy of undetermined significance. by Akiko Yamada (111970)

“…<p>Demographic and clinical characteristics of patients with newly diagnosed multiple myeloma and monoclonal gammopathy of undetermined significance.…”

The patients with PMR had a significant inflammatory gene expression profile, abundant inflammatory genes that may activate JAK signaling. by Xinlei Ma (1423633)

Subjects:

Data Sheet 1_Significance of multi-task deep learning neural networks for diagnosing clinically significant prostate cancer in plain abdominal CT.docx by Yujun Geng (21232145)

“…Objective<p>Early detection and timely surgical intervention are crucial in reducing mortality rates associated with clinically significant prostate cancer (csPCa). Currently, clinical diagnostics primarily depend on magnetic resonance imaging (MRI) and nuclear medicine, with the potential diagnostic value of abdominal computed tomography (CT) remaining underexplored. …”

Demand-side global autocorrelation analysis. by Shuang Lu (504608)

“…Based on land-use data for Jinan from 2006 to 2018, and using the spatial measurement tool GeoDa, we found that both green and residential space have increased significantly in central Jinan. …”

Demographic and clinical characteristics of patients diagnosed with COVID-19. by Rebeka Caribé Badin (14599893)

Supplementary Data 5 from Comprehensive Genomic Profiling Alters Clinical Diagnoses in a Significant Fraction of Tumors Suspicious of Sarcoma by Ingegerd Öfverholm (18828706)

Supplementary Figure 1 from Comprehensive Genomic Profiling Alters Clinical Diagnoses in a Significant Fraction of Tumors Suspicious of Sarcoma by Ingegerd Öfverholm (18828706)

Supplementary Data 6 from Comprehensive Genomic Profiling Alters Clinical Diagnoses in a Significant Fraction of Tumors Suspicious of Sarcoma by Ingegerd Öfverholm (18828706)

Supplementary Data 4 from Comprehensive Genomic Profiling Alters Clinical Diagnoses in a Significant Fraction of Tumors Suspicious of Sarcoma by Ingegerd Öfverholm (18828706)

Supplementary Data 8 from Comprehensive Genomic Profiling Alters Clinical Diagnoses in a Significant Fraction of Tumors Suspicious of Sarcoma by Ingegerd Öfverholm (18828706)

Table_1_Non-invasive Urine Test for Molecular Classification of Clinical Significance in Newly Diagnosed Prostate Cancer Patients.docx by Jinan Guo (8049647)

“…</p><p>Conclusions: The 24-Gene Classifier urine test is an accurate and non-invasive liquid biopsy method for identifying clinically significant prostate cancer in newly diagnosed cancer patients. …”

Supplementary Data 3 from Comprehensive Genomic Profiling Alters Clinical Diagnoses in a Significant Fraction of Tumors Suspicious of Sarcoma by Ingegerd Öfverholm (18828706)

Supplementary Data 7 from Comprehensive Genomic Profiling Alters Clinical Diagnoses in a Significant Fraction of Tumors Suspicious of Sarcoma by Ingegerd Öfverholm (18828706)

Supplementary Data 2 from Comprehensive Genomic Profiling Alters Clinical Diagnoses in a Significant Fraction of Tumors Suspicious of Sarcoma by Ingegerd Öfverholm (18828706)

Supplementary Data 1 from Comprehensive Genomic Profiling Alters Clinical Diagnoses in a Significant Fraction of Tumors Suspicious of Sarcoma by Ingegerd Öfverholm (18828706)

Supplementary Data 9 from Comprehensive Genomic Profiling Alters Clinical Diagnoses in a Significant Fraction of Tumors Suspicious of Sarcoma by Ingegerd Öfverholm (18828706)

ALK inhibitors (Positive control) and ABT199 (Proposed binding) in complex with the ALK active side. by Richard Junior Zapata Dongo (17912565)

Table_1_Tumor-Acidity Responsive Polymeric Nanoparticles for Targeting Delivery of Angiogenesis Inhibitor for Enhanced Antitumor Efficacy With Decreased Toxicity.docx by Xiufeng Cong (10361204)

“…<p>Various nanocarriers with tumor targeting ability and improved pharmacokinetic property have been extensively utilized to reduce the toxicity of existing clinical chemotherapeutics. Herein, we showed that by encapsulating angiogenesis inhibitor anlotinib into polymeric nanoparticles, we could significantly decrease its in vivo toxicity. …”